BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9839727)

  • 1. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening.
    Shapiro S; Coleman EA; Broeders M; Codd M; de Koning H; Fracheboud J; Moss S; Paci E; Stachenko S; Ballard-Barbash R
    Int J Epidemiol; 1998 Oct; 27(5):735-42. PubMed ID: 9839727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment.
    Ballard-Barbash R; Klabunde C; Paci E; Broeders M; Coleman EA; Fracheboud J; Bouchard F; Rennert G; Shapiro S
    Eur J Cancer Prev; 1999 Oct; 8(5):417-26. PubMed ID: 10548397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countries.
    Klabunde CN; Sancho-Garnier H; Taplin S; Thoresen S; Ohuchi N; Ballard-Barbash R;
    Int J Qual Health Care; 2002 Dec; 14(6):449-61. PubMed ID: 12515331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance for screening mammography: an international comparison.
    Klabunde C; Bouchard F; Taplin S; Scharpantgen A; Ballard-Barbash R;
    J Epidemiol Community Health; 2001 Mar; 55(3):204-12. PubMed ID: 11160176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical quality control practices in mammography screening programs in 22 countries.
    Hendrick RE; Klabunde C; Grivegnee A; Pou G; Ballard-Barbash R
    Int J Qual Health Care; 2002 Jun; 14(3):219-26. PubMed ID: 12108532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer screening programmes--results of studies in foreign countries--situation in Belgium.
    Vandenbroucke A; Bourdon C
    Eur J Cancer Prev; 1993 May; 2(3):269-74. PubMed ID: 8490549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results from an international survey.
    Deandrea S; Molina-Barceló A; Uluturk A; Moreno J; Neamtiu L; Peiró-Pérez R; Saz-Parkinson Z; Lopez-Alcalde J; Lerda D; Salas D
    Prev Med; 2016 Oct; 91():250-263. PubMed ID: 27527575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Population-Based Screening Mammography Programs Internationally.
    Klabunde CN; Ballard-Barbash R;
    Semin Breast Dis; 2007 Jun; 10(2):102-107. PubMed ID: 18516278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International comparison of performance measures for screening mammography: can it be done?
    Yankaskas BC; Klabunde CN; Ancelle-Park R; Renner G; Wang H; Fracheboud J; Pou G; Bulliard JL;
    J Med Screen; 2004; 11(4):187-93. PubMed ID: 15624239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of early performance indicators for screening projects within the European Breast Cancer Network: 1989-2000.
    Broeders MJ; Scharpantgen A; Ascunce N; Gairard B; Olsen AH; Mantellini P; Mota TC; Van Limbergen E; Séradour B; Ponti A; Trejo LS; Nyström L;
    Eur J Cancer Prev; 2005 Apr; 14(2):107-16. PubMed ID: 15785314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic screening programmes in Europe: organization, coverage and participation.
    Giordano L; von Karsa L; Tomatis M; Majek O; de Wolf C; Lancucki L; Hofvind S; Nyström L; Segnan N; Ponti A; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J J; Lancucki L; Ducarroz S; Suonio E
    J Med Screen; 2012; 19 Suppl 1():72-82. PubMed ID: 22972813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assurance for screening mammography data collection systems in 22 countries.
    Klabunde CN; Sancho-Garnier H; Broeders M; Thoresen S; Rodrigues VJ; Ballard-Barbash R
    Int J Technol Assess Health Care; 2001; 17(4):528-41. PubMed ID: 11758297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
    Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
    BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer screening programmes and self-reported mammography use in European countries.
    Cardoso R; Hoffmeister M; Brenner H
    Int J Cancer; 2023 Jun; 152(12):2512-2527. PubMed ID: 36883419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.
    Muratov S; Canelo-Aybar C; Tarride JE; Alonso-Coello P; Dimitrova N; Borisch B; Castells X; Duffy SW; Fitzpatrick P; Follmann M; Giordano L; Hofvind S; Lebeau A; Quinn C; Torresin A; Vialli C; Siesling S; Ponti A; Giorgi Rossi P; Schünemann H; Nyström L; Broeders M;
    BMC Cancer; 2020 Aug; 20(1):795. PubMed ID: 32831048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for breast cancer in Europe: achievements, problems, and future.
    Gad A; Thomas BA; Moskowitz M
    Recent Results Cancer Res; 1984; 90():179-94. PubMed ID: 6366953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMAS position statement: individualized breast cancer screening versus population-based mammography screening programmes.
    Depypere H; Desreux J; Pérez-López FR; Ceausu I; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; van der Schouw YT; Simoncini T; Tremollieres F; Rees M; EMAS
    Maturitas; 2014 Dec; 79(4):481-6. PubMed ID: 25277123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should breast cancer survivors be excluded from, or invited to, organised mammography screening programmes?
    Bucchi L
    BMC Health Serv Res; 2011 Oct; 11():249. PubMed ID: 21970334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs of mammography screening in New Zealand: evidence from the pilot programmes.
    Menon A; Devlin NJ; Richardson AK
    N Z Med J; 1994 Dec; 107(991):501-3. PubMed ID: 7830979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.